Intuitive Surgical, Inc.

369,10 EUR 0,05 (+0,01%)

Premiumpartner

Firmenbeschreibung

Intuitive Surgical, Inc. ist ein US-amerikanisches Medizintechnikunternehmen. Der Konzern gehört zu den führenden Anbietern von Robotersystemen, die innerhalb der minimal invasiven Chirurgie (MIS) eingesetzt werden. Kernprodukt des Unternehmens ist das sogenannte da Vinci®-System. Das eigens von Intuitive Surgical entwickelte Produkt wird sowohl bei Eingriffen im Thoraxbereich oder am Herzen als auch in der Urologie und Gynäkologie verwendet. Das System besteht aus einer Operationskonsole, einem hochauflösenden Bildschirmsystem mit 3D-Virtualisierung sowie patentierten Instrumenten. So bietet die Apparatur dem Benutzer die Möglichkeit, selbst schwierige Eingriffe und Operationen bei nur geringer Inzision noch präziser durchführen zu können. Zu den Kunden des Unternehmens gehören in erster Linie Krankenhäuser, außerdem wird das da Vinci®-System auch innerhalb des Militärs eingesetzt. Unter dem Dach der Intuitive Surgical, Inc. entwickeln und produzieren zahlreiche Tochterfirmen verschiedenartige Produkte, die innerhalb der operativen Medizin gebraucht werden. Die Tochtergesellschaften vertreiben die jeweiligen Produkte unter eigenem Markennamen. Hierzu gehören unter anderem: EndoWrist, da Vinci®-Si oder Single-Site. Außerdem arbeitet der Konzern mit verschiedenen anderen Unternehmen und Forschungszentren zusammen, um den technischen Standard seiner Produkte verbessern zu können. Das Unternehmen kooperiert mit dem Massachusetts Institute of Technology (MIT), Power Medical Interventions, InTouch Health und der John Hopkins Universität.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Vanguard Group Inc (8.44%),Blackrock Inc. (8.42%),Price (T.Rowe) Associates Inc (5.41%),State Street Corporation (4.21%),FMR, LLC (2.33%),JP Morgan Chase & Company (2.28%),Capital World Investors (2.14%),Bank Of New York Mellon Corporation (2.03%),Alliancebernstein L.P. (1.98%),Geode Capital Management, LLC (1.88%)
sharesOutstanding: 352325863.0000
ceo: Dr. Gary S. Guthart
board: Jamie Samath, Dave Rosa, Myriam J. Curet, Brian Miller, Bob DeSantis, Gary Loeb, Kara Andersen Reiter, Marshall L. Mohr, Henry Charlton, Marc Bland, Dirk Barten, Glenn Vavoso, Lesly Marban, Julian Nikolchev, Gillian S. Duncan, Chris Carlson, Iman Jeddi, Charlie Dean, Ian Purdy, Mark Brosius
supervisoryBoard: Craig H. Barratt, Dr. Gary S. Guthart, Joseph C. Beery, Amal M. Johnson, Don R. Kania, Amy L. Ladd, Keith R. Leonard, Alan J. Levy, Jami Dover Nachtsheim, Monica P. Reed, Mark J. Rubash
countryID: 20
freeFloat: 60.8800
faceValue: 0.0010
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Medizintechnische Produkte
industryName: Gesundheitswesen
subsectorName: Hochentwickelte medizinische Geräte
country: USA
countryName: USA

Kontakt

phone: +1-408-523-2161
email: investor.relations@intusurg.com
irWebSite: goo.gl/W5uRbZ

Adresse

street: 1020 Kifer Road, Building 101
city: Sunnyvale, California 94086-5304, USA
phone: +1-408-523-2100
fax: +1-408-523-1390
webSite: www.intuitivesurgical.com

Finanzen (kurz)

year: 2021 cash: 1290.9000
balanceSheetTotal: 13555.0000 liabilities: 1603.5000
shareCapital: 0.4000 totalShareholdersEquity: 11951.5000
sales: 5710.1000 investment: 0.0000
incomeBeforeTaxes: 1890.3000 netIncome: 1704.6000
cashFlow: -332.5000 employees: 9793
currencyID: 4 units: 1000000
currency: USD
year: 2022 cash: 1581.2000
balanceSheetTotal: 12974.0000 liabilities: 1861.4000
shareCapital: 0.4000 totalShareholdersEquity: 11112.6000
sales: 6222.2000 incomeBeforeTaxes: 1606.8000
netIncome: 1322.3000 cashFlow: 294.7000
currencyID: 4 units: 1000000
currency: USD
year: 2023 cash: 2750.1000
balanceSheetTotal: 15441.5000 liabilities: 2044.2000
shareCapital: 0.4000 totalShareholdersEquity: 13397.3000
sales: 7124.1000 incomeBeforeTaxes: 1958.9000
netIncome: 1798.0000 cashFlow: 1169.4000
currencyID: 4 units: 1000000
currency: USD

Finanzen (kurz)

year: 2021
cash: 1290.9000
balanceSheetTotal: 13555.0000
liabilities: 1603.5000
shareCapital: 0.4000
totalShareholdersEquity: 11951.5000
sales: 5710.1000
investment: 0.0000
incomeBeforeTaxes: 1890.3000
netIncome: 1704.6000
cashFlow: -332.5000
employees: 9793
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 1581.2000
balanceSheetTotal: 12974.0000
liabilities: 1861.4000
shareCapital: 0.4000
totalShareholdersEquity: 11112.6000
sales: 6222.2000
incomeBeforeTaxes: 1606.8000
netIncome: 1322.3000
cashFlow: 294.7000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 2750.1000
balanceSheetTotal: 15441.5000
liabilities: 2044.2000
shareCapital: 0.4000
totalShareholdersEquity: 13397.3000
sales: 7124.1000
incomeBeforeTaxes: 1958.9000
netIncome: 1798.0000
cashFlow: 1169.4000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 12974.0000 cash: 1581.2000
currentAssets: 6253.0000 fixedAssets: 6721.0000
liabilities: 1422.1000 totalLiabilitiesEquity: 12974.0000
totalShareholdersEquity: 11112.6000 property: 2374.2000
longTermInvestments: 2623.6000 inventories: 893.2000
accountsReceivable: 942.1000 accountsPayable: 147.0000
liabilitiesTotal: 1861.4000 minorityInterests: 70.7000
commonStock: 0.4000 preferredStock: 0.0000
sales: 6222.2000 depreciation: 365.8000
netIncome: 1322.3000 operatingResult: 1577.1000
incomeInterest: 29.7000 investments: 879.0000
incomeTaxes: 262.4000 costGoodsSold: 2026.2000
grossProfit: 4196.0000 minorityInterestsProfit: 22.1000
cashFlow: 1490.8000 cashFlowInvesting: 1370.8000
cashFlowFinancing: -2572.3000 cashFlowTotal: 294.7000
accountingStandard: US GAAP equityRatio: 85.6528
debtEquityRatio: 16.7504 liquidityI: 111.1877
liquidityII: 177.4348 netMargin: 21.2513
grossMargin: 67.4360 cashFlowMargin: 23.9594
ebitMargin: 25.3463 ebitdaMargin: 0.0000
preTaxROE: 14.4593 preTaxROA: 12.3848
roe: 11.8991 roa: 10.1919
netIncomeGrowth: -22.4275 revenuesGrowth: 8.9683
taxExpenseRate: 16.3306 equityTurnover: 0.5599
epsBasic: 3.7200 epsDiluted: 3.6500
epsBasicGrowth: -22.3382 shareCapital: 0.4000
incomeBeforeTaxes: 1606.8000 priceEarningsRatioCompany: 71.3306
priceCashFlowRatio: 62.3664 bookValuePerShare: 31.7150
marketCap: 92975901322.6500 earningsYield: 1.4019
pegRatio: -3.1932 cashFlowPerShare: 4.2547
netAssetsPerShare: 31.9168 priceBookValueRatio: 8.3667
priceEarningsRatio: 70.3138 netEarningsPerShare: 3.7738
currency: USD
year: 2023 units: 1000000
balanceSheetTotal: 15441.5000 cash: 2750.1000
currentAssets: 7888.0000 fixedAssets: 7553.5000
liabilities: 1658.7000 totalLiabilitiesEquity: 15441.5000
totalShareholdersEquity: 13397.3000 property: 3537.6000
longTermInvestments: 2120.0000 inventories: 1220.6000
accountsReceivable: 1130.2000 accountsPayable: 188.7000
liabilitiesTotal: 2044.2000 minorityInterests: 89.7000
commonStock: 0.4000 preferredStock: 0.0000
sales: 7124.1000 depreciation: 421.8000
netIncome: 1798.0000 operatingResult: 1766.8000
incomeInterest: 192.1000 investments: 998.8000
incomeTaxes: 141.6000 costGoodsSold: 2394.6000
grossProfit: 4729.5000 minorityInterestsProfit: 19.3000
cashFlow: 1813.8000 cashFlowInvesting: -360.1000
cashFlowFinancing: -287.6000 cashFlowTotal: 1169.4000
accountingStandard: US GAAP equityRatio: 86.7616
debtEquityRatio: 15.2583 liquidityI: 165.7985
liquidityII: 233.9362 netMargin: 25.2383
grossMargin: 66.3873 cashFlowMargin: 25.4601
ebitMargin: 24.8003 ebitdaMargin: 0.0000
preTaxROE: 14.6216 preTaxROA: 12.6859
roe: 13.4206 roa: 11.6439
netIncomeGrowth: 35.9752 revenuesGrowth: 14.4949
taxExpenseRate: 7.2285 equityTurnover: 0.5318
epsBasic: 5.1200 epsDiluted: 5.0300
epsBasicGrowth: 37.6344 shareCapital: 0.4000
incomeBeforeTaxes: 1958.9000 priceEarningsRatioCompany: 65.8906
priceCashFlowRatio: 65.5313 bookValuePerShare: 38.0253
marketCap: 118860653141.6800 earningsYield: 1.5177
pegRatio: 1.7508 cashFlowPerShare: 5.1481
netAssetsPerShare: 38.2799 priceBookValueRatio: 8.8720
priceEarningsRatio: 66.1071 netEarningsPerShare: 5.1032
currency: USD
year: 2024 priceEarningsRatioCompany: 77.9473
priceCashFlowRatio: 77.5222 bookValuePerShare: 38.0253
marketCap: 140609728664.6700 earningsYield: 1.2829
pegRatio: 2.0712 cashFlowPerShare: 5.1481
netAssetsPerShare: 38.0253 priceBookValueRatio: 10.4954
priceEarningsRatio: 78.2034 netEarningsPerShare: 5.1032
currency: USD

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 12974.0000
cash: 1581.2000
currentAssets: 6253.0000
fixedAssets: 6721.0000
liabilities: 1422.1000
totalLiabilitiesEquity: 12974.0000
totalShareholdersEquity: 11112.6000
property: 2374.2000
longTermInvestments: 2623.6000
inventories: 893.2000
accountsReceivable: 942.1000
accountsPayable: 147.0000
liabilitiesTotal: 1861.4000
minorityInterests: 70.7000
commonStock: 0.4000
preferredStock: 0.0000
sales: 6222.2000
depreciation: 365.8000
netIncome: 1322.3000
operatingResult: 1577.1000
incomeInterest: 29.7000
investments: 879.0000
incomeTaxes: 262.4000
costGoodsSold: 2026.2000
grossProfit: 4196.0000
minorityInterestsProfit: 22.1000
cashFlow: 1490.8000
cashFlowInvesting: 1370.8000
cashFlowFinancing: -2572.3000
cashFlowTotal: 294.7000
accountingStandard: US GAAP
equityRatio: 85.6528
debtEquityRatio: 16.7504
liquidityI: 111.1877
liquidityII: 177.4348
netMargin: 21.2513
grossMargin: 67.4360
cashFlowMargin: 23.9594
ebitMargin: 25.3463
ebitdaMargin: 0.0000
preTaxROE: 14.4593
preTaxROA: 12.3848
roe: 11.8991
roa: 10.1919
netIncomeGrowth: -22.4275
revenuesGrowth: 8.9683
taxExpenseRate: 16.3306
equityTurnover: 0.5599
epsBasic: 3.7200
epsDiluted: 3.6500
epsBasicGrowth: -22.3382
shareCapital: 0.4000
incomeBeforeTaxes: 1606.8000
priceEarningsRatioCompany: 71.3306
priceCashFlowRatio: 62.3664
bookValuePerShare: 31.7150
marketCap: 92975901322.6500
earningsYield: 1.4019
pegRatio: -3.1932
cashFlowPerShare: 4.2547
netAssetsPerShare: 31.9168
priceBookValueRatio: 8.3667
priceEarningsRatio: 70.3138
netEarningsPerShare: 3.7738
currency: USD
year: 2023
units: 1000000
balanceSheetTotal: 15441.5000
cash: 2750.1000
currentAssets: 7888.0000
fixedAssets: 7553.5000
liabilities: 1658.7000
totalLiabilitiesEquity: 15441.5000
totalShareholdersEquity: 13397.3000
property: 3537.6000
longTermInvestments: 2120.0000
inventories: 1220.6000
accountsReceivable: 1130.2000
accountsPayable: 188.7000
liabilitiesTotal: 2044.2000
minorityInterests: 89.7000
commonStock: 0.4000
preferredStock: 0.0000
sales: 7124.1000
depreciation: 421.8000
netIncome: 1798.0000
operatingResult: 1766.8000
incomeInterest: 192.1000
investments: 998.8000
incomeTaxes: 141.6000
costGoodsSold: 2394.6000
grossProfit: 4729.5000
minorityInterestsProfit: 19.3000
cashFlow: 1813.8000
cashFlowInvesting: -360.1000
cashFlowFinancing: -287.6000
cashFlowTotal: 1169.4000
accountingStandard: US GAAP
equityRatio: 86.7616
debtEquityRatio: 15.2583
liquidityI: 165.7985
liquidityII: 233.9362
netMargin: 25.2383
grossMargin: 66.3873
cashFlowMargin: 25.4601
ebitMargin: 24.8003
ebitdaMargin: 0.0000
preTaxROE: 14.6216
preTaxROA: 12.6859
roe: 13.4206
roa: 11.6439
netIncomeGrowth: 35.9752
revenuesGrowth: 14.4949
taxExpenseRate: 7.2285
equityTurnover: 0.5318
epsBasic: 5.1200
epsDiluted: 5.0300
epsBasicGrowth: 37.6344
shareCapital: 0.4000
incomeBeforeTaxes: 1958.9000
priceEarningsRatioCompany: 65.8906
priceCashFlowRatio: 65.5313
bookValuePerShare: 38.0253
marketCap: 118860653141.6800
earningsYield: 1.5177
pegRatio: 1.7508
cashFlowPerShare: 5.1481
netAssetsPerShare: 38.2799
priceBookValueRatio: 8.8720
priceEarningsRatio: 66.1071
netEarningsPerShare: 5.1032
currency: USD
year: 2024
priceEarningsRatioCompany: 77.9473
priceCashFlowRatio: 77.5222
bookValuePerShare: 38.0253
marketCap: 140609728664.6700
earningsYield: 1.2829
pegRatio: 2.0712
cashFlowPerShare: 5.1481
netAssetsPerShare: 38.0253
priceBookValueRatio: 10.4954
priceEarningsRatio: 78.2034
netEarningsPerShare: 5.1032
currency: USD